Zura Bio Ltd (ZURA) Financial Statements
Industry: Biological Products, (No Diagnostic Substances)
In fiscal 2025, Zura Bio reported revenue of $0. Net income was -$68.7M, or -$1.06 per diluted share. Operating activities generated -$64.8M of cash, leaving -$64.9M of free cash flow. At fiscal year end, Zura Bio held $113.9M in total assets against $12.4M in total liabilities, including $109.4M of cash and equivalents.
Open the full interactive Zura Bio financials → Quarterly statements, key ratios, valuation history and price charts.
Zura Bio Key Stats
| Share Price | $4.23 |
|---|---|
| Market Cap | $536.4M |
| 52-Week Range | $3.21 – $7.04 |
| Shares Outstanding | 126.8 million (basic, 2026 Q2) |
Zura Bio Income Statement
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Income | -$2.7M | -$62.6M | -$55.2M | -$75.2M |
| Pre-Tax Income | $3.5M | -$60.6M | -$52.4M | -$68.7M |
| Income Tax | — | $0 | $0 | — |
| Net Income | $3.5M | -$60.4M | -$52.4M | -$68.7M |
| Diluted EPS | $0.21 | -$2.09 | -$0.60 | -$1.06 |
Zura Bio Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Net Income | -$18.0M | -$17.2M | -$24.2M | -$26.3M |
| Diluted EPS | -$0.21 | -$0.18 | -$0.22 | -$0.21 |
Zura Bio Balance Sheet
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|
| Cash & Equivalents | $13,785 | $99.8M | $176.5M | $109.4M |
| Current Assets | $33,487 | $100.8M | $178.7M | $112.3M |
| Total Assets | $141.5M | $100.8M | $179.5M | $113.9M |
| Current Liabilities | $1.8M | $20.3M | $19.5M | $12.4M |
| Total Liabilities | $7.8M | $21.3M | $19.5M | $12.4M |
| Shareholders' Equity | -$7.6M | $59.3M | $146.8M | $101.5M |
Zura Bio Cash Flow Statement
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|
| Cash From Operations | -$1.1M | -$15.1M | -$28.1M | -$64.8M |
| Cash From Investing | — | -$8.0M | -$5.1M | -$113,000 |
| Cash From Financing | $355,595 | $121.3M | $109.8M | -$2.2M |
| Free Cash Flow | — | — | -$28.2M | -$64.9M |
Figures from Zura Bio's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Zura Bio financials page for every line item.
Zura Bio Company Profile
| Ticker | ZURA |
|---|---|
| Exchange | Nasdaq |
| Industry | Biological Products, (No Diagnostic Substances) |
| Headquarters | La Jolla, California |
| Fiscal Year End | December 31 |
| SEC Filer Category | Emerging growth company |
| SEC CIK | 0001855644 |
Frequently Asked Questions
What was Zura Bio's revenue in fiscal 2025?
Zura Bio (ZURA) reported revenue of $0 for fiscal 2025.
What is Zura Bio's annual revenue history?
Zura Bio's annual revenue by fiscal year: 2022: $0; 2023: $0; 2024: $0; 2025: $0.
What was Zura Bio's net income in fiscal 2025?
Zura Bio reported net income of -$68.7M for fiscal 2025.
What was Zura Bio's earnings per share (EPS) in fiscal 2025?
Zura Bio's diluted EPS was -$1.06 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Zura Bio generate in fiscal 2025?
Zura Bio generated -$64.9M of free cash flow in fiscal 2025.
What was Zura Bio's revenue last quarter?
In its most recent reported quarter (2026 Q2), Zura Bio reported revenue of $0.
How many shares of Zura Bio are outstanding?
Zura Bio reported a weighted average of 126.8 million basic shares outstanding in 2026 Q2.
What is Zura Bio's market cap?
Based on its latest closing price, Zura Bio (ZURA) has a market capitalization of about $536.4M.
When does Zura Bio's fiscal year end?
Zura Bio's fiscal year end, as registered with the SEC, is December 31.
Where is Zura Bio headquartered?
Zura Bio lists its business address in La Jolla, California in its SEC filings.
Zura Bio Competitors & Similar Companies
See all 136 Biological Products, (No Diagnostic Substances) companies →